Goldzieher J W, Chenault C B, De La Pena A, Dozier T S, Kraemer D C
Fertil Steril. 1978 Aug;30(2):146-53. doi: 10.1016/s0015-0282(16)43452-7.
Human subjects, baboons, and beagles were given cyclic regimens of ethynylestradiol or mestranol; after a number of such cycles, concurrent administration of norethindrone acetate, dl-norgestrel, or megestrol acetate was introduced for a similar number of cycles. Carbohydrate tolerance was evaluated by oral glucose tolerance testing in the human subjects and by intravenous glucose tolerance testing in the baboons and beagles. In the human subjects, neither mestranol nor ethynylestradiol at daily doses of 50 to 100 microgram/day produced any effect on fasting glucose levels or on glucose tolerance even after six cycles of treatment. The addition of the progestational compounds also had no effect on these two variables. In baboons, ethynylestradiol and mestranol were bioequivalent and produced a dose-related decrease in the glucose disposal rate. All three progestational agents counteracted this effect in a comparable manner. In beagles, on the other hand, estrogens produced an increase in the glucose disposal rate, and the addition of progestational agents produced an initial fall and a subsequent return to pretreatment levels.
对人类受试者、狒狒和比格犬给予炔雌醇或炔诺醇的周期性给药方案;在进行若干个这样的周期后,引入醋酸炔诺酮、dl-炔诺孕酮或醋酸甲地孕酮同时给药,持续相似数量的周期。通过对人类受试者进行口服葡萄糖耐量试验以及对狒狒和比格犬进行静脉葡萄糖耐量试验来评估碳水化合物耐受性。在人类受试者中,每日剂量为50至100微克/天的炔诺醇或炔雌醇,即使在六个治疗周期后,对空腹血糖水平或葡萄糖耐量也没有产生任何影响。添加孕激素类化合物对这两个变量也没有影响。在狒狒中,炔雌醇和炔诺醇具有生物等效性,并使葡萄糖处置率呈剂量相关下降。所有三种孕激素类药物以类似方式抵消了这种作用。另一方面,在比格犬中,雌激素使葡萄糖处置率增加,添加孕激素类药物则导致最初下降,随后又恢复到治疗前水平。